Future options for management of heart failure in an emergency department observation unit

Critical Pathways in Cardiology

Volumn 4, Issue 4, 2005, Pages 177-181

  Peacock, W Frank ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Dialysis; Emergency department; Heart failure; Heart sounds; Nesiritide; Observation; Physical diagnosis; Ultrafiltration

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOBUTAMINE; FUROSEMIDE; GLYCERYL TRINITRATE; LOOP DIURETIC AGENT; NESIRITIDE;

ACUTE KIDNEY FAILURE; ARTICLE; AUSCULTATION; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; EMERGENCY WARD; EXTRACORPOREAL CIRCULATION; GENERAL PRACTITIONER; HEART FAILURE; HEART SOUND; HUMAN; HYPOTENSION; INFUSION; KIDNEY DISEASE; OLIGURIA; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; ULTRAFILTRATION;

EID: 28144459888     PISSN: 1535282X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hpc.0000188385.92077.44     Document Type: Article

References (17)

1. Peacock FW, Emerman CL for the ADHERE; Scientific Advisory Committee and Investigators. Evolving patterns of care for decompensated heart failure: implications from the ADHERE registry database. Acad Emerg Med. 2004;11:503.
2. Bayliss J, Norell M, Canepa-Anson R, et al. Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics. Br Heart J. 1987;57:17-22.
3. Gottlieb SS, Brater DC, Thomas I, et al. BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy. Circulation. 2002;106:1743.
4. Francis GS, Siegel RM, Goldsmith SR, et al. Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Activation of the neurohumoral axis. Ann Int Med. 1985; 103:1-6.
5. Jaski BE, Ha J, Denys BG, et al. Peripherally inserted veno-venous ultrafiltration for rapid treatment of volume overloaded patients. J Card Fail. 2003;9:227-231.
6. Peacock WF 4th, Remer EE, Aponte J, et al. Effective observation unit treatment of decompensated heart failure. Congestive Heart Failure. 2002;8:68-73.
7. Joshi N. The third heart sound. South Med J. 1999;92:756-761.
8. Abrams J. Current concepts of the genesis of heart sounds. II. Third and fourth sounds. JAMA. 1978;239:2790-2727.
9. Mangione S, Nieman LZ. Cardiac auscultation skill of internal medicine and family practice trainees: a comparison of diagnostic proficiency. JAMA. 1997;278:717-722.
10. Ishmail AA, Wing S, Ferguson J, et al. Interobserver agreement by auscultation in the presence of a third heart sound in patients with congestive heart failure. Chest. 1987;91:870-873.
11. Lok CE, Morgan CD, Ranganathan N. The accuracy and interobserver agreement in detecting the 'gallop sounds' by cardiac auscultation. Chest. 1998;114:1283-1288.
12. Drazner MH, Rame JE, Stevenson LW, et al. Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure. N Engl J Med. 2001;345:574-581.
13. Collins SP, Lindsell CJ, Peacock WF, et al. Prevalence of S3 and S4 in emergency department patients with decompensated heart failure. Ann EM. 2004;44(suppl):S98.
14. Cuffe MS, Califf RM, Adams KFJ, et al. for the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) Investigators. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. JAMA. 2002;287:1541-1547.
15. Burger AJ, Horton DP, LeJemtel T, et al. Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventriculararrhythmias in the treatment of patients with acutely decompensated congestive heart failure: the PRECEDENT Study. Am Heart J. 2002;144:1102-1108.
16. Packer M, Cohn JN. Consensus recommendations for the management of chronic heart failure. Am J Cardiol. 1999;83(2A):1A-38A.
17. Yancy CW, Saltzberg MT, Berkowitz RL, et al. Safety and feasibility of using serial infusions of Nesiritide for heart failure in an outpatient setting (from the FUSION I Trial). Am J Cardiol. 2004;94:595-601.